PHAC/CIHR Influenza Research Network
9
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
11.1%
1 terminated/withdrawn out of 9 trials
85.7%
-0.8% vs industry average
33%
3 trials in Phase 3/4
33%
2 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Influenza Vaccine Safety and Effectiveness in Healthcare Providers
Role: collaborator
H1N1 Vaccine in Pregnancy: a Registry for the Fall and Winter of 2009
Role: collaborator
Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children
Role: collaborator
Comparison of 4 Influenza Vaccines in Seniors
Role: collaborator
Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Aboriginal Children and Adults
Role: collaborator
LAIV (Flumist®) Administration in CF Patients
Role: collaborator
Surveillance for Adverse Events Following Influenza Immunization
Role: lead
Surveillance for Adverse Events Following Pandemic H1N1 Immunization
Role: lead
Clinical Investigation on Allergic-like Reactions and Oculo-respiratory Syndrome After the H1N1 Pandemic Vaccine
Role: lead
All 9 trials loaded